Cargando…
Retracted: Downregulation of ADAM10 Expression Inhibits Metastasis and Invasiveness of Human Hepatocellular Carcinoma HepG2 Cells
Autor principal: | BioMed Research International |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020525/ https://www.ncbi.nlm.nih.gov/pubmed/24868522 http://dx.doi.org/10.1155/2014/308263 |
Ejemplares similares
-
Retracted: In Vitro Evaluation of Cytotoxic Potential of Caladium lindenii Extracts on Human Hepatocarcinoma HepG2 and Normal HEK293T Cell Lines
por: International, BioMed Research
Publicado: (2023) -
Retracted: Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
por: International, BioMed Research
Publicado: (2023) -
Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016) -
Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: BioMed Research International,
Publicado: (2018) -
Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
por: International, BioMed Research
Publicado: (2021)